Answers are grounded in this paper and cite their sources.
Investigates pyran-core derivative 5e's effects on basal-like TNBC, highlighting its potential as an anticancer agent.
This study investigates the nonsymmetrical pentanoid derivative 5e as a selective anticancer agent against basal-like triple-negative breast cancer (TNBC). The pyran-core derivative 5e demonstrated significant selectivity, effectively suppressing the proliferation of basal-like TNBC HCC-1806 cells (IC50 = 0.59 ± 0.16 µM; selectivity index = 2–6). Mechanistic studies indicated that 5e attenuates proteasome degradation activity via the ubiquitin-proteasome pathway. By promoting the accumulation of ubiquitinated oncoproteins, 5e induces G2/M cell cycle arrest and triggers both early and late apoptosis in HCC-1806 cells. Molecular docking simulations further revealed that 5e forms stable interactions with the β5 subunit binding site of the 20S proteasome.
No takes yet. Share an insight, caveat, or question.
Yen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: